| scholarly article | Q13442814 |
| P2093 | author name string | Maj M | |
| Bartoli L | |||
| Pirozzi R | |||
| Magliano L | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lithium | Q568 |
| bipolar disorder | Q131755 | ||
| patient | Q181600 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 30-35 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic | |
| P478 | volume | 155 |
| Q35066482 | 50 Years with lithium treatment in affective disorders: present problems and priorities |
| Q43808435 | A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients |
| Q37632466 | A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder |
| Q30884720 | A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. |
| Q44789674 | A survival analysis for recurrent events in psychiatric research |
| Q92892412 | A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder |
| Q44671658 | Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study |
| Q30482552 | An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). |
| Q48913237 | Anatomical MRI study of basal ganglia in bipolar disorder patients |
| Q35236134 | Anticonvulsant drugs in bipolar disorder. |
| Q28597251 | Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series. |
| Q34804607 | Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report |
| Q45347657 | Association between lithium serum level, mood state, and patient-reported adverse drug reactions during long-term lithium treatment: a naturalistic follow-up study |
| Q38023889 | Beyond the guidelines for bipolar disorder: practical issues in long-term treatment with lithium. |
| Q34052830 | Bipolar disorder therapeutics: maintenance treatment |
| Q34825573 | Cognitive manic symptoms in bipolar disorder associated with polymorphisms in the DAOA and COMT genes |
| Q35757918 | Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders |
| Q34777367 | Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder |
| Q34108459 | Current concepts in rapid cycling bipolar disorder |
| Q34521351 | Current research on rapid cycling bipolar disorder and its treatment |
| Q79951368 | Do benzodiazepines extend the duration of follow-up treatment in patients with bipolar disorder? |
| Q44434685 | Do clinicians understand why individuals stop taking lithium? |
| Q34768852 | Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms? |
| Q44380467 | Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. |
| Q37612716 | Does the "Silver Bullet" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients |
| Q33673659 | Donepezil in treatment-resistant bipolar disorder. |
| Q33876177 | Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders. |
| Q83215397 | Easing the burden of bipolar disorder: from urgent situations to remission |
| Q92319584 | Episodic density, subsyndromic symptoms, and mood instability in late-life bipolar disorders: A 5-year follow-up study |
| Q48105673 | Five-year outcome of bipolar I and II disorders: findings of the Jorvi Bipolar Study |
| Q35561522 | Gender differences in bipolar disorder |
| Q50802689 | Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications. |
| Q41126795 | Inverted battery design as ion generator for interfacing with biosystems. |
| Q73091030 | Lamotrigine and the treatment of bipolar disorder. Introduction |
| Q33753315 | Lamotrigine and the treatment of mania in bipolar disorder |
| Q28081249 | Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics |
| Q34609171 | Lithium long-term treatment in mood disorders: clinical and genetic predictors |
| Q37954426 | Lithium: still a major option in the management of bipolar disorder. |
| Q44094247 | Long-term outcome of lithium prophylaxis in bipolar disorder with mood-incongruent psychotic features: a prospective study |
| Q36327271 | Long-term remission and recovery in bipolar disorder: a review |
| Q44464135 | Maintenance efficacy of divalproex in the prevention of bipolar depression |
| Q34106695 | Maintenance therapies for classic and other forms of bipolar disorder |
| Q36210974 | Maintenance therapies in bipolar disorder: focus on randomized controlled trials |
| Q33879251 | Mania and ADHD: comorbidity or confusion |
| Q45070768 | Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features |
| Q51083721 | Methodological considerations for the development of new treatments for bipolar disorder. |
| Q40416216 | Neurochemical underpinnings in bipolar disorder and epilepsy |
| Q46401105 | Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval. |
| Q39444069 | New perspectives in the treatment of acute mania: a single case report |
| Q51539330 | Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder. |
| Q34204347 | Novel treatments for bipolar disorder |
| Q38214588 | Olanzapine discontinuation emergent recurrence in bipolar disorder. |
| Q80397920 | Oxcarbazepine versus Divalproex Sodium for the Continuing Treatment of Mania |
| Q48619553 | Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study |
| Q28216643 | Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants |
| Q37115466 | Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service |
| Q33895446 | Placebo control groups in randomized treatment trials: a statistician's perspective |
| Q36361982 | Polytherapy in bipolar disorder |
| Q34098311 | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. |
| Q35217473 | Prophylaxis latency and outcome in bipolar disorders |
| Q33753321 | Prophylaxis of bipolar disorder: how and who should we treat in the long term? |
| Q36011838 | Psychological therapies for bipolar disorder: the role of model-driven approaches to therapy integration |
| Q52066927 | Psychotropic drug prescription patterns among patients with bipolar I disorder. |
| Q37402290 | Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment |
| Q36532149 | Rapid cycling bipolar disorders in primary and tertiary care treated patients. |
| Q35884680 | Rethinking the treatment paradigm for bipolar depression: the importance of long-term management |
| Q36199036 | Safety and tolerability of emerging pharmacological treatments for bipolar disorder |
| Q60628028 | Seasonal variations of lithium plasma levels |
| Q48352742 | Self-management strategies used by 'high functioning' individuals with bipolar disorder: from research to clinical practice |
| Q60628034 | Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders |
| Q43932430 | Serotonin transporter gene associated with lithium prophylaxis in mood disorders. |
| Q34504598 | Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients |
| Q48711473 | Symptoms and treatment of bipolar patients in Sweden. |
| Q35041599 | The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder |
| Q53657532 | The Maudsley bipolar disorder project. Clinical characteristics of bipolar disorder I in a Catchment area treatment sample. |
| Q34550618 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment |
| Q34649187 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder |
| Q34108582 | The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse |
| Q36293345 | The behavioral actions of lithium in rodent models: leads to develop novel therapeutics |
| Q37777005 | The clinical spectrum of bipolar symptoms in epilepsy: a critical reappraisal |
| Q35142731 | The effect of lithium in bipolar disorder: a review of recent research evidence |
| Q34185336 | The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence |
| Q43682742 | The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. |
| Q36128822 | The management of bipolar disorder in primary care: a review of existing and emerging therapies |
| Q61875945 | The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s |
| Q73727431 | The relatively good prognosis of bipolar disorders in a Turkish bipolar clinic |
| Q35693563 | Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders |
| Q36397305 | Treatment considerations for patients experiencing rapid-cycling bipolar disorder |
| Q60628045 | Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders11This work was partially supported by the BIOMED 2 grant BMH4-CT97-2307 |
| Q35025965 | Unique design issues in clinical trials of patients with bipolar affective disorder |
| Q36263641 | Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders |
| Q41658786 | Who are excellent lithium responders and why do they matter? |
| Q35022930 | Women and bipolar disorder across the life span |
| Q79905002 | [Prognostic aspects of bipolar disorders] |
| Q83190702 | [The costs of bipolar disorder] |
| Q57698064 | Évolution du trouble bipolaire |
Search more.